Thailand Diabetes Registry Project: Glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage

Journal of the Medical Association of Thailand

Volumn 89, Issue SUPPL. 1, 2006, Pages

  Kosachunhanun, Natapong ^a   Benjasuratwong, Yupin ^b   Mongkolsomlit, Sirima ^c   Rawdaree, Petch ^c   Plengvidhya, Nattachet ^d   Leelawatana, Rattana ^e   Bunnag, Pongamorn ^f   Pratipanawatr, Thongchai ^g   Krittiyawong, Sirinate ^h   Suwanwalaikorn, Sompongse ⁱ   Deerochanawong, Chaicharn ^j   Chetthakul, Thanya ^k   Ngarmukos, Chardpraorn ^f   Komoltri, Chulaluk ^d  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b Phramongkutklao Hospital   (Thailand)

^c NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

^e PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^f MAHIDOL UNIVERSITY   (Thailand)

^g KHON KAEN UNIVERSITY   (Thailand)

^h Theptarin General Hospital   (Thailand)

ⁱ CHULALONGKORN UNIVERSITY   (Thailand)

^j RAJAVITHI HOSPITAL   (Thailand)

^k MAHARAT NAKHON RATCHASIMA HOSPITAL   (Thailand)

more..

Author keywords

Diabetes; Diabetes registry; Glycemic control; Hypoglycemic agents

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; INSULIN; METFORMIN; REPAGLINIDE; SULFONYLUREA;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET THERAPY; DISEASE DURATION; DISEASE REGISTRY; DRUG USE; FEMALE; GLYCEMIC CONTROL; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION; PREVALENCE; TERTIARY HEALTH CARE; THAILAND; UNIVERSITY HOSPITAL;

CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; REGISTRIES; SULFONYLUREA COMPOUNDS; THAILAND; THIAZOLIDINEDIONES; TREATMENT OUTCOME;

EID: 33845456138     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Wild S, Roglic G, Green A, Sicree R, King H, Wild S. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
2. Aekplakorn W, Stolk RP, Neal B, Suriyawongpaisal P, Chongsuvivatwong V, Cheepudomwit S, et al. INTERASIA Collaborative Group. The prevalence and management of diabetes in Thai adults: the international collaborative study of cardiovascular disease in Asia. Diabetes Care 2003; 26: 2758-63.
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-53.
4. IDF Clinical Guidelines Task Force. Global guideline for Type 2 diabetes.Brussels:International Diabetes Federation, 2005.
5. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.Canadian Journal of Diabetes 2003; 27: S37-42.
6. American Diabetes Association. Clinical practice recommendation: standard of medical care in diabetes. Diabetes Care 2005; 28(Suppl 1): S4-36.
7. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-86.
8. Beaton S, Nag S, Gunter M, Gleeson J, Sajjan S, Alexander C. Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. Diabetes Care 2004; 27: 694-8.
9. Eliasson B, Cederholm J, Nilsson P, Gudbjornsdottir S. for the Steering Committee of the Swedish National Diabetes Register. The gap between guidelines and reality: type 2 diabetes in a national diabetes register 1996-2003. Diabet Med 2005; 22: 1420-6.
10. Chuang LM, Tsai ST, Huang BY, Tai TY. DIABCARE (Taiwan) Study Group. The current state of diabetes management in Taiwan. Diabetes Res Clin Pract 2001; 54: S55-65.
11. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.Lancet 1998; 352: 854-65.
12. Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH,Rutten GE,Van Weel C. Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.Diabetes Care 2005; 28: 154-63.
13. Marre M. Before oral agents fail: the case for starting insulin early. Int J Obes Relat Metab Disord 2002; 26(Suppl 3): S25-30.
14. Viberti G. Rosiglitazone:potential beneficial impact on cardiovascular disease.Int J Clin Pract 2003; 57: 128-34.
15. Zimmet P. Addressing the insulin resistance syndrome. A role for the thiazolidinediones. Trends Cardiovasc Med 2002; 12: 354-62.
16. Rawdaree P, Ngarmukos C, Deerochanawong C, Suwanwalaikorn S, Chetthakul T, Krittiyawong S, et al. Thailand diabetes registry project: clinical status and long term vascular complications in diabetic patients. J Med Assoc Thai 2006; 89(Suppl 1): S1-9.